Search details
1.
Comprehensive Analysis of Hypermutation in Human Cancer.
Cell
; 171(5): 1042-1056.e10, 2017 Nov 16.
Article
in English
| MEDLINE | ID: mdl-29056344
2.
Enrollment on upfront high-risk neuroblastoma trials by race, ethnicity, and poverty status: A report from the Children's Oncology Group.
Pediatr Blood Cancer
; 71(7): e31051, 2024 Jul.
Article
in English
| MEDLINE | ID: mdl-38706187
3.
Survival effect of complete surgical resection of the primary tumor in patients with metastatic, high-risk neuroblastoma in a large Canadian cohort.
Pediatr Blood Cancer
; 70(6): e30286, 2023 06.
Article
in English
| MEDLINE | ID: mdl-36975166
4.
Children's Oncology Group's 2023 blueprint for research: Neuroblastoma.
Pediatr Blood Cancer
; 70 Suppl 6: e30572, 2023 09.
Article
in English
| MEDLINE | ID: mdl-37458162
5.
Combination mTOR and SHP2 inhibitor treatment of lymphatic malformation endothelial cells.
Microvasc Res
; 143: 104397, 2022 09.
Article
in English
| MEDLINE | ID: mdl-35671835
6.
Temporal clustering of neuroblastic tumours in children and young adults from Ontario, Canada.
Environ Health
; 21(1): 30, 2022 03 07.
Article
in English
| MEDLINE | ID: mdl-35255910
7.
Ceritinib in paediatric patients with anaplastic lymphoma kinase-positive malignancies: an open-label, multicentre, phase 1, dose-escalation and dose-expansion study.
Lancet Oncol
; 22(12): 1764-1776, 2021 12.
Article
in English
| MEDLINE | ID: mdl-34780709
8.
Residual meta-iodobenzyl guanidine (MIBG) positivity following therapy for metastatic neuroblastoma: Patient characteristics, imaging, and outcome.
Pediatr Blood Cancer
; 68(12): e29289, 2021 12.
Article
in English
| MEDLINE | ID: mdl-34411405
9.
A nomogram of clinical and biologic factors to predict survival in children newly diagnosed with high-risk neuroblastoma: An International Neuroblastoma Risk Group project.
Pediatr Blood Cancer
; 68(3): e28794, 2021 03.
Article
in English
| MEDLINE | ID: mdl-33205902
10.
The ganglioside GD2 as a circulating tumor biomarker for neuroblastoma.
Pediatr Blood Cancer
; 67(1): e28031, 2020 01.
Article
in English
| MEDLINE | ID: mdl-31612589
11.
The Role of Surgery in High-risk Neuroblastoma.
J Pediatr Hematol Oncol
; 42(1): 1-7, 2020 01.
Article
in English
| MEDLINE | ID: mdl-31599856
12.
Developing a Faculty Awards Strategy in an Academic Department: Recognizing Faculty and Promoting the Department.
J Pediatr
; : 113899, 2024 Jan 03.
Article
in English
| MEDLINE | ID: mdl-38181977
13.
An upfront immunomodulatory therapy protocol for pediatric opsoclonus-myoclonus syndrome.
Pediatr Blood Cancer
; 66(8): e27776, 2019 08.
Article
in English
| MEDLINE | ID: mdl-31033188
14.
The challenge of defining "ultra-high-risk" neuroblastoma.
Pediatr Blood Cancer
; 66(4): e27556, 2019 04.
Article
in English
| MEDLINE | ID: mdl-30479064
15.
Prevalence and Clinical Correlations of Somatostatin Receptor-2 (SSTR2) Expression in Neuroblastoma.
J Pediatr Hematol Oncol
; 41(3): 222-227, 2019 04.
Article
in English
| MEDLINE | ID: mdl-30334904
16.
MYCN Amplified Relapse Following Resolution of MYCN Nonamplified 4S Neuroblastoma With Placental Involvement: A Case Report and Review of the Literature.
J Pediatr Hematol Oncol
; 41(5): 388-391, 2019 Jul.
Article
in English
| MEDLINE | ID: mdl-31094905
17.
Characteristics and management of ganglioneuroma and ganglioneuroblastoma-intermixed in children and adolescents.
Pediatr Blood Cancer
; 65(5): e26964, 2018 05.
Article
in English
| MEDLINE | ID: mdl-29369484
18.
Autologous stem cell transplantation for refractory opsoclonus myoclonus ataxia syndrome.
Pediatr Blood Cancer
; 65(8): e27110, 2018 08.
Article
in English
| MEDLINE | ID: mdl-29693780
19.
Retrospective evaluation of a decision-support algorithm (MIPOGG) for genetic referrals for children with neuroblastic tumors.
Pediatr Blood Cancer
; 65(12): e27390, 2018 12.
Article
in English
| MEDLINE | ID: mdl-30117275
20.
Phase I study of vorinostat in combination with isotretinoin in patients with refractory/recurrent neuroblastoma: A new approaches to Neuroblastoma Therapy (NANT) trial.
Pediatr Blood Cancer
; 65(7): e27023, 2018 07.
Article
in English
| MEDLINE | ID: mdl-29603591